CDIO | tickerfilter.com

Fundamental analysis

42%

Profitability 35%

Dept financing 25%

Liquidity 50%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.19%

1 Month

-3.19%

3 Months

0.55%

6 Months

-53.45%

1 Year

303.82%

2 Year

163.77%

Key data

Stock price

$1.82

P/E Ratio

N/A

DAY RANGE

$1.80 - $1.89

EPS

-$2.85

52 WEEK RANGE

$0.15 - $7.91

52 WEEK CHANGE

$303.82

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

2.959 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

2.95

PUBLIC FLOAT

AVERAGE 10 VOLUME

$44,411

AVERAGE 30 VOLUME

$80,242

Company detail

CEO: Meeshanthini Dogan
Region: US
Website: cardiodiagnosticsinc.com
Employees: 1
IPO year: 2022

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Mana Capital Acquisition Corp. focuses on engaging in a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Dover, Delaware.

CDIO - Cardio Diagnostics Holdings Inc